Lobbying Activity Report

4636-49377

Organization: Apotex Inc.
Associated registration: 10049-4636-6
Lobbying Activity date: 2026-02-10
Arranged a meeting: No
Posted date: 2026-02-18

In-house lobbyists who participated in the lobbying activity: Matthew Southcott
Senior Public Office Holders who were lobbied in this activity: Susan Bouma, Executive Director
Pharmacy Clinical Services & Evaluation, Health

Lanlin Bu, Governance and Planning Analyst
Transformation & Corporate Reporting, Health

John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement Branch, Health

Tijana Fazlagic, Executive Director
PharmaCare Benefits Branch, Health

Catherine Patterson, Director
Transformation & Corporate Reporting, Health

Ian Rongve, ADM
Health System Policy & Oversight, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Ongoing interactions related to increased and sustainable utilization of cost-saving generic and biosimilar medicines, and a predictable and viable business environment for generic medicines.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Government Procurement, Health
 
Senior officer who filed this Lobbying Activity Report: Raymond Shelley
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: